257 related articles for article (PubMed ID: 28102204)
21. Adrenalectomy Completely Cured Hypertension in Patients With Familial Hyperaldosteronism Type I Who Had Somatic KCNJ5 Mutation.
Lin YF; Peng KY; Chang CH; Hu YH; Wu VC; Chueh JS; Wu KD
J Clin Endocrinol Metab; 2019 Nov; 104(11):5462-5466. PubMed ID: 31287546
[TBL] [Abstract][Full Text] [Related]
22. a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III.
Monticone S; Hattangady NG; Penton D; Isales CM; Edwards MA; Williams TA; Sterner C; Warth R; Mulatero P; Rainey WE
J Clin Endocrinol Metab; 2013 Nov; 98(11):E1861-5. PubMed ID: 24037882
[TBL] [Abstract][Full Text] [Related]
23. Cellular and Genetic Causes of Idiopathic Hyperaldosteronism.
Omata K; Satoh F; Morimoto R; Ito S; Yamazaki Y; Nakamura Y; Anand SK; Guo Z; Stowasser M; Sasano H; Tomlins SA; Rainey WE
Hypertension; 2018 Oct; 72(4):874-880. PubMed ID: 30354720
[TBL] [Abstract][Full Text] [Related]
24. KCNJ5 Somatic Mutation Is a Predictor of Hypertension Remission After Adrenalectomy for Unilateral Primary Aldosteronism.
Vilela LAP; Rassi-Cruz M; Guimaraes AG; Moises CCS; Freitas TC; Alencar NP; Petenuci J; Goldbaum TS; Maciel AAW; Pereira MAA; Silva GV; Pio-Abreu A; Zerbini MCN; Cavalcante ACBS; Carnevale FC; Pilan B; Yamauchi F; Srougi V; Tanno FY; Chambo JL; Latronico AC; Mendonca BB; Fragoso MCBV; Bortolotto LA; Drager LF; Almeida MQ
J Clin Endocrinol Metab; 2019 Oct; 104(10):4695-4702. PubMed ID: 31216002
[TBL] [Abstract][Full Text] [Related]
25. Somatic mutations in the KCNJ5 gene raise the lateralization index: implications for the diagnosis of primary aldosteronism by adrenal vein sampling.
Seccia TM; Mantero F; Letizia C; Kuppusamy M; Caroccia B; Barisa M; Cicala MV; Miotto D; Rossi GP
J Clin Endocrinol Metab; 2012 Dec; 97(12):E2307-13. PubMed ID: 23012392
[TBL] [Abstract][Full Text] [Related]
26. CTNNB1 Mutation in Aldosterone Producing Adenoma.
Wang JJ; Peng KY; Wu VC; Tseng FY; Wu KD
Endocrinol Metab (Seoul); 2017 Sep; 32(3):332-338. PubMed ID: 28956362
[TBL] [Abstract][Full Text] [Related]
27. Comparison of cardiovascular complications in patients with and without KCNJ5 gene mutations harboring aldosterone-producing adenomas.
Kitamoto T; Suematsu S; Matsuzawa Y; Saito J; Omura M; Nishikawa T
J Atheroscler Thromb; 2015; 22(2):191-200. PubMed ID: 25253161
[TBL] [Abstract][Full Text] [Related]
28. KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma.
Kitamoto T; Omura M; Suematsu S; Saito J; Nishikawa T
J Hypertens; 2018 Mar; 36(3):619-627. PubMed ID: 29016532
[TBL] [Abstract][Full Text] [Related]
29. Genetic and Histopathologic Intertumor Heterogeneity in Primary Aldosteronism.
Omata K; Yamazaki Y; Nakamura Y; Anand SK; Barletta JA; Sasano H; Rainey WE; Tomlins SA; Vaidya A
J Clin Endocrinol Metab; 2017 Jun; 102(6):1792-1796. PubMed ID: 28368480
[TBL] [Abstract][Full Text] [Related]
30. Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTH-dependent aldosterone hypersecretion.
Sertedaki A; Markou A; Vlachakis D; Kossida S; Campanac E; Hoffman DA; Sierra ML; Xekouki P; Stratakis CA; Kaltsas G; Piaditis GP; Chrousos GP; Charmandari E
Clin Endocrinol (Oxf); 2016 Dec; 85(6):845-851. PubMed ID: 27293068
[TBL] [Abstract][Full Text] [Related]
31. Hypomethylation of CYP11B2 in Aldosterone-Producing Adenoma.
Yoshii Y; Oki K; Gomez-Sanchez CE; Ohno H; Itcho K; Kobuke K; Yoneda M
Hypertension; 2016 Dec; 68(6):1432-1437. PubMed ID: 27754862
[TBL] [Abstract][Full Text] [Related]
32. Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutations.
Nanba K; Omata K; Tomlins SA; Giordano TJ; Hammer GD; Rainey WE; Else T
Eur J Endocrinol; 2016 Aug; 175(2):K1-6. PubMed ID: 27165862
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular and metabolic characters of
Chang YY; Lee BC; Chen ZW; Tsai CH; Chang CC; Liao CW; Pan CT; Peng KY; Chou CH; Lu CC; Wu VC; Hung CS; Lin YH;
Front Endocrinol (Lausanne); 2023; 14():1061704. PubMed ID: 36950676
[TBL] [Abstract][Full Text] [Related]
34. KCNJ5 gene somatic mutations affect cardiac remodelling but do not preclude cure of high blood pressure and regression of left ventricular hypertrophy in primary aldosteronism.
Rossi GP; Cesari M; Letizia C; Seccia TM; Cicala MV; Zinnamosca L; Kuppusamy M; Mareso S; Sciomer S; Iacobone M; Mantero F; Pessina AC
J Hypertens; 2014 Jul; 32(7):1514-21; discussion 1522. PubMed ID: 24759126
[TBL] [Abstract][Full Text] [Related]
35. miRNA299 involvement in CYP11B2 expression in aldosterone-producing adenoma.
Nakano Y; Yoshimoto T; Watanabe R; Murakami M; Fukuda T; Saito K; Fujii Y; Akashi T; Tanaka T; Yamada T; Naruse M; Ogawa Y
Eur J Endocrinol; 2019 Jul; 181(1):69-78. PubMed ID: 31096184
[TBL] [Abstract][Full Text] [Related]
36. Macrolides Blunt Aldosterone Biosynthesis: A Proof-of-Concept Study in
Caroccia B; Prisco S; Seccia TM; Piazza M; Maiolino G; Rossi GP
Hypertension; 2017 Dec; 70(6):1238-1242. PubMed ID: 28993452
[TBL] [Abstract][Full Text] [Related]
37. Primary Aldosteronism: KCNJ5 Mutations and Adrenocortical Cell Growth.
Yang Y; Gomez-Sanchez CE; Jaquin D; Aristizabal Prada ET; Meyer LS; Knösel T; Schneider H; Beuschlein F; Reincke M; Williams TA
Hypertension; 2019 Oct; 74(4):809-816. PubMed ID: 31446799
[TBL] [Abstract][Full Text] [Related]
38. New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5.
Scholl UI; Lifton RP
Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):141-7. PubMed ID: 23318698
[TBL] [Abstract][Full Text] [Related]
39. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
40. Somatic mutations in adrenals from patients with primary aldosteronism not cured after adrenalectomy suggest common pathogenic mechanisms between unilateral and bilateral disease.
Hacini I; De Sousa K; Boulkroun S; Meatchi T; Amar L; Zennaro MC; Fernandes-Rosa FL
Eur J Endocrinol; 2021 Aug; 185(3):405-412. PubMed ID: 34232123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
